First and only AKT inhibitor approved in Japan for breast cancer patients with specific biomarker alterations
The inspection at Unit 1 by the USFDA has been successfully completed, with no observations under Form 483
Dr Madhu will oversee Apollo's hospital business and will focus on continuing to deliver the world's best clinical outcomes
Both organisations enter into a long- term collaboration to expand patient access in India
Vision loss due to Glaucoma can be prevented if it is detected and treated early
ANVISA issues CGMP to Concord Biotech’s Unit I
Dr Sheth's will commission a Healthmobile on Wheels initiative to ensure that healthcare doesn't remain confined to urban centers
Connecting new production and consumption areas of chilled food by low-carbon transportation services
_256_384.jpg)
The overall transaction is expected to conclude over next 12-15 months subject to receipt of all relevant shareholder and regulatory approvals
These re-agent and diagnostic test kits come with 99.7% accuracy
Subscribe To Our Newsletter & Stay Updated
